Computerized Cognitive Training for Psychosis
(STEP (P4) Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests computerized cognitive training to help individuals with psychotic illnesses better understand and process their surroundings. Researchers compare two types of training to assess their effects on brain activity and task performance. The study seeks participants who speak English well and have an IQ of 70 or higher, particularly those with stable schizophrenia or similar conditions. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance cognitive therapies for psychotic illnesses.
Do I have to stop taking my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team to understand any specific requirements.
What prior data suggests that this computerized cognitive training is safe for individuals with psychosis?
Research shows that computerized cognitive training is generally safe for people. Studies have found it is well-tolerated by individuals with conditions like depression and schizophrenia. This training has been used in various clinical settings without major safety issues.
For Perceptual Discrimination Training, evidence indicates that cognitive training, which aims to improve mental skills, has been safely used in people with schizophrenia. These programs have reported no major side effects.
Similarly, Visual Cognitive Control Training uses computerized methods and is also considered safe. Reviews of its use in people with psychosis-related disorders have found no serious safety concerns.
Both types of training adjust to each person's progress, ensuring the exercises remain challenging but manageable. Overall, past experiences suggest these training exercises are safe to participate in.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for psychosis because they focus on enhancing cognitive abilities through computerized exercises, a novel approach compared to standard medications like antipsychotics. Perceptual Discrimination Training sharpens visual processing and attention by challenging participants to identify subtle differences in visual stimuli, which adapts to their skill level. Meanwhile, Visual Cognitive Control Training boosts working memory and cognitive flexibility by requiring participants to remember and apply rules while interacting with visual stimuli. This adaptive, game-like method is distinct from traditional treatments and could offer a non-pharmaceutical way to improve cognitive functions in individuals with psychosis.
What evidence suggests that this trial's cognitive training treatments could be effective for psychosis?
This trial will compare two types of Computerized Cognitive Training for individuals with psychosis. Studies have shown that Perceptual Discrimination Training, one of the methods in this trial, can significantly improve how people with schizophrenia perceive and understand moving objects. This training helps them distinguish between important information and distractions, a challenge for those with psychotic conditions. Research has found that this training can quickly enhance their ability to manage complex visual tasks.
Visual Cognitive Control Training, another method tested in this trial, has research supporting its effectiveness in boosting thinking skills in people with schizophrenia. This training helps individuals remember information and choose appropriate actions, improving decision-making and mental flexibility. Evidence suggests that these exercises enhance overall mental health and cognitive abilities, making them promising tools for those with psychotic disorders.678910Who Is on the Research Team?
Sophia Vinogradov, M.D.
Principal Investigator
University of Minnesota
Angus MacDonald III, Ph.D.
Principal Investigator
University of Minnesota
Are You a Good Fit for This Trial?
This trial is for individuals aged 15-40 with a recent diagnosis of psychosis or related conditions, who speak English and have an IQ above 70. They must be clinically stable, not pregnant, non-dependent on substances, and without major medical or neurological issues.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Cognitive Training
Participants complete 10 hours of computerized cognitive training over a 3-6 week period
Post-Intervention Follow-up
Participants undergo post-intervention assessments including interviews, questionnaires, neurocognitive assessments, and imaging appointments
Long-term Follow-up
Participants are monitored for changes in cognitive performance and symptoms 5 months after intervention
What Are the Treatments Tested in This Trial?
Interventions
- Computerized Cognitive Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator